April/May #187 : An Almost Normal Life Expectancy? - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents


Recovering Your Life

Navigating Treatment as Prevention

From the Editor

High Hopes


Letters-April/May 2013


Positive Support

POZ Planet

Return to Sender

Old-School Kicks

My Bloody Valentine

Talk of the Town

Safe Sex 3.0

Bar None

Coming Attractions


What Would You Do?

Care and Treatment

The Heart of Cardiovascular Risks

E-Reminders Help Patient Outcomes

HIV Docs Slow on Early Treatment

TasP in the Real World

An Almost Normal Life Expectancy?

Research Notes

Prevention: Spinning Beyond Latex and Gels

Treatment: Fulyzaq Approved for Diarrhea Relief

Cure: Embryo Survival Gene to Control HIV

Concerns: HIV-Positive Smokers Lose More Years

POZ Survey Says

Facing Discrimination

POZ Heroes

Not Lost in Translation

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

April / May 2013

An Almost Normal Life Expectancy?

by Benjamin Ryan

According to a U.K. study, people with HIV may enjoy a close to normal life expectancy—if they remain on antiretroviral (ARV) therapy, maintain a suppressed viral load and a CD4 count above 350, are uninfected with hepatitis B or C, and do not use injection drugs.

“Working with the current rates,” says the study’s lead author Margaret May, PhD, a reader in medical statistics at the University of Bristol’s School of Social and Community Medicine, “it seems to us that people with HIV are likely to live long lives, similar with having other diseases which are well-controlled.”

Basing its projections on a theoretical 35-year-old man who has been on HIV treatment for five years, the study found that those with CD4 counts above 350 could expect to live to 77 on average. On the flip side, those without an undetectable viral load would lose 11 years of life expectancy, and those with less than 200 CD4s could expect to live only to 55.

May pushes earlier treatment for people with HIV, saying, “It really matters that you start treatment before you get immunosuppressed. And it also matters that you’re virally suppressed once you are on treatment. Because both of those are contributing independently to life expectancy.”

A major caveat of May’s research, however, is that she and her colleagues did not factor in potential downsides to long-term ARV therapy, including potential liver and kidney toxicities, that may affect mortality rates among people with HIV.

Search: HIV positive people, antiretroviral therapy, life expectancy, undetectable viral load

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.